Literature DB >> 32014888

Correction: Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy.

Carmela Passaro, Quazim Alayo, Isabel DeLaura, John McNulty, Korneel Grauwet, Hirotaka Ito, Vivek Bhaskaran, Marco Mineo, Sean E Lawler, Khalid Shah, Maria C Speranza, William Goins, Eric McLaughlin, Soledad Fernandez, David A Reardon, Gordon J Freeman, E Antonio Chiocca, Hiroshi Nakashima.   

Abstract

Entities:  

Year:  2020        PMID： 32014888     DOI： 10.1158/1078-0432.CCR-19-4091

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  2 in total

Review 1.  Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicity.

Authors:  Alicia Teijeira Crespo; Stephanie Burnell; Lorenzo Capitani; Rebecca Bayliss; Elise Moses; Georgina H Mason; James A Davies; Andrew J Godkin; Awen M Gallimore; Alan L Parker
Journal:  Immunology       Date:  2021-03-28       Impact factor: 7.215

2.  Tumour microenvironment: Modulating effects, challenges, and future perspectives of oncolytic virotherapy in Astrocytoma treatment.

Authors:  Wireko Andrew Awuah; Helen Huang; Jacob Kalmanovich; Aashna Mehta; Mrinmoy Kundu; Abdul Rahman Toufik; Resham Tanna; Mohammad Mehedi Hasan; Athanasios Alexiou; Vladyslav Sikora
Journal:  Ann Med Surg (Lond)       Date:  2022-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.